• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2,5,6-三氯-1-(β-D-呋喃核糖基)苯并咪唑某些5'-修饰类似物的合成及抗病毒活性

Synthesis and antiviral activity of certain 5'-modified analogs of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.

作者信息

Gudmundsson K S, Drach J C, Wotring L L, Townsend L B

机构信息

Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor 49019-1065, USA.

出版信息

J Med Chem. 1997 Feb 28;40(5):785-93. doi: 10.1021/jm9604888.

DOI:10.1021/jm9604888
PMID:9057865
Abstract

A series of 5'-modified 2,5,6-trichlorobenzimidazole ribonucleosides has been synthesized and tested for activity against two human herpesviruses and for cytotoxicity. The 5'-methoxy, 5'-ethoxy, and 5'-butoxy analogs of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole (TCRB) were prepared by coupling the appropriate 5-O-alkyl-1,2,3-tri-O-acetyl-beta-D-ribose derivatives with 2,5,6-trichlorobenzimidazole followed by removal of the protecting groups. The 5'-deoxy-5'-fluoro, -5'-chloro, -5'-bromo, -5'-iodo, -5'-azido, and -5'-thiomethyl derivatives were synthesized in a similar fashion. All of these 5'-modified derivatives had significant activity against HCMV in plaque and yield reduction assays (IC50's = 0.5-14.2 microM) but had little activity (IC50's > 100 microM) against HSV-1. This pattern in similar to the antiviral activity profile observed for TCRB. The 5'-halogenated derivatives were more active than the other 5'-modified derivatives with antiviral activity well separated from cytotoxicity. In general, cytotoxicity of all the 5'-modified derivatives was greater in human foreskin fibroblasts (HFF cells) than in L1210 or KB tumor cells. These results indicate that the viral target tolerates significant modifications of TCRB at the 5'-position without adversely affecting activity against HCMV, whereas the 5'-modifications increased cytotoxicity in human diploid cells.

摘要

已合成了一系列5'-修饰的2,5,6-三氯苯并咪唑核糖核苷,并测试了它们对两种人类疱疹病毒的活性和细胞毒性。通过将适当的5-O-烷基-1,2,3-三-O-乙酰基-β-D-核糖衍生物与2,5,6-三氯苯并咪唑偶联,然后除去保护基团,制备了2,5,6-三氯-1-(β-D-呋喃核糖基)苯并咪唑(TCRB)的5'-甲氧基、5'-乙氧基和5'-丁氧基类似物。5'-脱氧-5'-氟、-5'-氯、-5'-溴、-5'-碘、-5'-叠氮基和-5'-硫代甲基衍生物以类似方式合成。所有这些5'-修饰的衍生物在蚀斑和产量降低试验中对人巨细胞病毒(HCMV)具有显著活性(IC50 = 0.5-14.2 microM),但对单纯疱疹病毒1型(HSV-1)几乎没有活性(IC50 > 100 microM)。这种模式与观察到的TCRB的抗病毒活性谱相似。5'-卤代衍生物比其他5'-修饰的衍生物更具活性,其抗病毒活性与细胞毒性有很好的区分。一般来说,所有5'-修饰衍生物在人包皮成纤维细胞(HFF细胞)中的细胞毒性比在L1210或KB肿瘤细胞中更大。这些结果表明,病毒靶点能够耐受TCRB在5'-位的显著修饰,而不会对针对HCMV的活性产生不利影响,而5'-修饰增加了人二倍体细胞中的细胞毒性。

相似文献

1
Synthesis and antiviral activity of certain 5'-modified analogs of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.2,5,6-三氯-1-(β-D-呋喃核糖基)苯并咪唑某些5'-修饰类似物的合成及抗病毒活性
J Med Chem. 1997 Feb 28;40(5):785-93. doi: 10.1021/jm9604888.
2
Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.2-取代的4,5-二氯-和4,6-二氯-1-β-D-呋喃核糖基苯并咪唑作为人巨细胞病毒感染潜在药物的设计、合成及抗病毒评价
J Med Chem. 1997 Feb 28;40(5):802-10. doi: 10.1021/jm960533b.
3
Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.2-氯-5,6-二卤代-1-β-D-呋喃核糖基苯并咪唑作为人巨细胞病毒感染潜在药物的设计、合成及抗病毒评价
J Med Chem. 1997 Feb 28;40(5):811-8. doi: 10.1021/jm960462g.
4
Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.α-核苷的设计、合成及抗病毒活性:呋喃核糖基和(5-脱氧呋喃核糖基)苯并咪唑的D-和L-异构体
J Med Chem. 1998 Apr 9;41(8):1242-51. doi: 10.1021/jm970545c.
5
Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides.碳水化合物修饰的吡咯并[2,3-d]哒嗪-7-酮核苷的合成及其抗增殖和抗病毒活性
J Med Chem. 1997 Feb 28;40(5):794-801. doi: 10.1021/jm960631x.
6
Structure-activity relationships among 2-substituted 5,6-dichloro-, 4,6-dichloro-, and 4,5-dichloro-1-[(2-hydroxyethoxy) methyl]- and -1-[(1,3-dihydroxy-2-propoxy) methyl]benzimidazoles.2-取代的5,6-二氯-、4,6-二氯-和4,5-二氯-1-[(2-羟基乙氧基)甲基]-以及-1-[(1,3-二羟基-2-丙氧基)甲基]苯并咪唑类化合物的构效关系
J Med Chem. 1996 Feb 16;39(4):881-91. doi: 10.1021/jm950556a.
7
Synthesis and antiviral evaluation of polyhalogenated imidazole nucleosides: dimensional analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.多卤代咪唑核苷的合成与抗病毒评估:2,5,6-三氯-1-(β-D-呋喃核糖基)苯并咪唑的尺寸类似物
J Med Chem. 2004 Nov 4;47(23):5743-52. doi: 10.1021/jm040016q.
8
Synthesis of fluorosugar analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole as antivirals with potentially increased glycosidic bond stability.
J Med Chem. 2000 Jun 15;43(12):2473-8. doi: 10.1021/jm990219s.
9
Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles.某些2,5,6-三卤代-1-(β-D-呋喃核糖基)苯并咪唑的设计、合成及抗病毒活性
J Med Chem. 1995 Sep 29;38(20):4098-105. doi: 10.1021/jm00020a025.
10
Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.1-(取代苄基)-2-取代-5,6-二氯苯并咪唑作为2,5,6-三氯-1-(β-D-呋喃核糖基)苯并咪唑非核苷类似物的设计、合成及抗病毒评价
J Med Chem. 1998 Apr 9;41(8):1252-62. doi: 10.1021/jm970559i.

引用本文的文献

1
Benzimidazole(s): synthons, bioactive lead structures, total synthesis, and the profiling of major bioactive categories.苯并咪唑类:合成子、生物活性先导结构、全合成以及主要生物活性类别的剖析。
RSC Adv. 2025 Mar 28;15(10):7571-7608. doi: 10.1039/d4ra08864f. eCollection 2025 Mar 6.
2
Ethyl 1-(2-hy-droxy-eth-yl)-2-(4-meth-oxy-phen-yl)-1H-benzimidazole-5-carboxyl-ate monohydrate.1-(2-羟乙基)-2-(4-甲氧基苯基)-1H-苯并咪唑-5-羧酸乙酯一水合物
Acta Crystallogr Sect E Struct Rep Online. 2012 Feb 1;68(Pt 2):o421. doi: 10.1107/S1600536812001262. Epub 2012 Jan 18.
3
Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus.
β-D-核糖基苯并咪唑的磷酸化对于抗人巨细胞病毒活性并非必需。
Antimicrob Agents Chemother. 2002 Feb;46(2):478-86. doi: 10.1128/AAC.46.2.478-486.2002.